Norgine Limited

Norgine House, Widewater Place, Moorhall Road, Harefield, Middlesex, UB9 6NS
Telephone: +44 (0)1895 826 600
Fax: +44 (0)1895 825 865
E-mail:
Medical Information e-mail: medinfo@norgine.com

Patient Information Leaflet last updated on the eMC: 12/10/2010
PIL CAMCOLIT 400

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/10/2010 and displayed until Current
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 22/09/2010 and displayed until 12/10/2010
Reasons for adding or updating:
  • Change/addition of instructions for reconstitution and/ or administration
Updated on 05/05/2009 and displayed until 22/09/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 06/11/2006 and displayed until 05/05/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to date of revision
Updated on 16/05/2005 and displayed until 06/11/2006
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to storage instructions
  • Change to date of revision
Updated on 17/01/2005 and displayed until 16/05/2005
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
   lithium carbonate